Cargando…

Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The emergence of olaparib, a poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitor to treat metastatic castration-resistant prostate cancer (mCRPC), created a measurable clinical question on whether the agent positively influences the treatment outcomes and acceptable saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warli, Syah Mirsya, Velaro, Adrian Joshua, Firsty, Naufal Nandita, Tala, Zaimah Zulkarnaini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681786/ https://www.ncbi.nlm.nih.gov/pubmed/38022404 http://dx.doi.org/10.14740/wjon1685

Ejemplares similares

The Olfaction Ability of Medical Detection Canine to Detect Prostate Cancer From Urine Samples: Progress Captured in Systematic Review and Meta-Analysis
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Correlation between Soil Transmitted Helminth Infection and Eosinophil Levels among Primary School Children in Medan
por: Darlan, Dewi Masyithah, et al.
Publicado: (2017)

Correlation between Soil-Transmitted Helminths Infection and Serum Iron Level among Primary School Children in Medan
por: Arrasyid, Nurfida K., et al.
Publicado: (2017)

Evaluation of Paclitaxel, Ifosfamide, and Cisplatin (TIP) Regimen on Penile Cancer in Adam Malik Medan: A Single Center 2 Years of Experience
por: Sitompul, Ardiansyah Periadi, et al.
Publicado: (2019)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

P53 and Survival Rate in Penile Cancer
por: Prapiska, Fauriski Febrian, et al.
Publicado: (2019)

Diagnostic Value of Platelet–To-Lymphocyte Ratio in Prostate Cancer
por: Adhyatma, Kharisma Prasetya, et al.
Publicado: (2019)

Correlation between neutrophil–to-lymphocyte ratio with Gleason score in patients with prostate cancer at Adam Malik Hospital Medan 2013 – 2015
por: Rulando, Michael, et al.
Publicado: (2021)

Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2018)

Correlation Between Tumor-Associated Collagen Signature and Fibroblast Activation Protein Expression With Prognosis of Clear Cell Renal Cell Carcinoma Patient
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Hypoxia-Mesenchymal Stem Cells Inhibit Intra-Peritoneal Adhesions Formation by Upregulation of the IL-10 Expression
por: Muhar, Adi Muradi, et al.
Publicado: (2019)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

The Combination of CDK 4/6 Inhibitors plus Endocrine Treatment versus Endocrine Treatment Alone in Hormone-receptor (HR)-Positive breast Cancer: a Systematic Review and Meta-analysis
por: Hermansyah, Dedy, et al.
Publicado: (2022)

Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio
por: Adhyatma, Kharisma Prasetya, et al.
Publicado: (2019)

Complete Response of Rare Sarcomatoid Upper Tract Urothelial Carcinoma Variant: Case Report and Literature Review
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Metachronous bilateral testicular germ cell tumors with different histopathology: A case report
por: Valentino Torry, Stivano Rizky, et al.
Publicado: (2023)

A Rare Case of Sarcomatoid Renal Cell Carcinoma in a Young Adult Patient
por: Warli, Syah Mirsya, et al.
Publicado: (2022)

Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients
por: Warli, Syah Mirsya, et al.
Publicado: (2022)

Poor prognosis of urothelial carcinoma in patients presented with persistent paraneoplastic leukocytosis with anemia
por: Warli, Syah Mirsya, et al.
Publicado: (2022)

Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Bilateral synchronous testicular cancer: A case report
por: Ginting, Jeremy Thompson, et al.
Publicado: (2023)

Nephrolithiasis-Associated Renal Cell Carcinoma in Patients Who Underwent Nephrectomy: A Single-Center Experience
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Evaluation of Health-Related Quality of Life in Patients Receiving Treatment for Penile Cancer: A Single-Center Cross-Sectional Study
por: Firmansyah, Firmansyah, et al.
Publicado: (2023)

The Efficacy and Safety of Avanafil During a Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
por: Su, Dan, et al.
Publicado: (2021)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
por: Fallara, Giuseppe, et al.
Publicado: (2023)

Cat-Scratch Lymphadenitis Presenting with Right Upper Arm and Axillary Masses: a Case Report Mimicking Lymphoma and Potential Diagnostic Pitfall
por: Hermansyah, Dedy, et al.
Publicado: (2022)

First reported case of adult paratesticular myxofibrosarcoma in Indonesia: Case report and literature review
por: Respati, Eggi, et al.
Publicado: (2022)

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022)

D-dimer as a Predictive Factor of Axillary Lymph Node Metastases in Operable Breast Cancer Patients in the Teaching Hospital of Universitas Sumatera Utara
por: Hermansyah, Dedy, et al.
Publicado: (2022)

High platelet count as a predicting factor of histopathological grading among invasive breast cancer individuals: a single centre experience from Indonesia
por: Hermansyah, Dedy, et al.
Publicado: (2023)

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
por: Chen, Xiangyu, et al.
Publicado: (2023)

The Assessment of Male Erectile Dysfunction Characteristics in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Using the International Index of Erectile Function (IIEF-5) Combined with Hospital Anxiety and Depression Scales
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
por: Ma, Yi, et al.
Publicado: (2018)

Umbilical Cord-Derived Mesenchymal Stem Cells Improve TGF-β, α-SMA and Collagen on Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Mukti, Ade Indra, et al.
Publicado: (2022)

Changes in thyroid function in prostate cancer patients receiving docetaxel chemotherapy at Haji Adam Malik Hospital, Indonesia
por: Firman, Al, et al.
Publicado: (2023)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
por: Hu, Jason, et al.
Publicado: (2022)

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
por: Karzai, Fatima, et al.
Publicado: (2018)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
por: LeVee, Alexis, et al.
Publicado: (2021)

Cost-effectiveness of olaparib, a PARP inhibitor, for patients with metastatic castration-resistant prostate cancer in China and United States
por: Xu, Chenxia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dhomsi0t5a133s62lpp08rgiuf